Innate immunity in the vagina (Part i): Estradiol inhibits hbd2 and elafin secretion by human vaginal epithelial cells

American Journal of Reproductive Immunology

Volumn 69, Issue 5, 2013, Pages 463-474

  Patel, Mickey V ^a   Fahey, John V ^a   Rossoll, Richard M ^a   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Antimicrobials; Epithelial cells; Estradiol; Hormones; Human immunodeficiency virus; Innate immunity; Progesterone; Selective estrogen response modulators; Vagina

Indexed keywords

CELL PROTEIN; ELAFIN; ESTRADIOL; HUMAN BETA DEFENSIN 2; PROGESTERONE; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; VAGINA EPITHELIUM;

ADULT; ANTI-HIV AGENTS; BETA-DEFENSINS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ELAFIN; EPITHELIAL CELLS; ESTRADIOL; FEMALE; HUMANS; IMMUNITY, INNATE; MIDDLE AGED; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; VAGINA;

EID: 84876343589     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12078     Document Type: Article

References (49)

1. World Health Organization: Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. 2011.
2. Patton DL, Thwin SS, Meier A, Hooton TM, Stapleton AE, Eschenbach DA: Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000; 183:967-973.
3. Owen DH, Katz DF: A vaginal fluid simulant. Contraception 1999; 59:91-95.
4. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR: Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS ONE 2010; 5:e11366.
5. Wira CR, Ghosh M, Smith JM, Shen L, Connor RI, Sundstrom P, Frechette GM, Hill ET, Fahey JV: Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol 2011; 4:335-342.
6. John M, Keller MJ, Fam EH, Cheshenko N, Hogarty K, Kasowitz A, Wallenstein S, Carlucci MJ, Tuyama AC, Lu W, Klotman ME, Lehrer RI, Herold BC: Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis 2005; 192:1731-1740.
7. Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, Szell M, Dobozy A, Kemeny L: Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells. Microbes Infect 2005; 7:1117-1127.
8. Klotman ME, Chang TL: Defensins in innate antiviral immunity. Nat Rev Immunol 2006; 6:447-456.
9. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A: Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003; 17:F39-F48.
10. Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, Berrone S, Kleinman C, Wu Z, Abdelwahab S, Lu W, Garzino-Demo A: Human β-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 2005; 79:14318-14329.
11. Weinberg A, Quinones-Mateu ME, Lederman MM: Role of human beta-defensins in HIV infection. Adv Dent Res 2006; 19:42-48.
12. Reading JL, Meyers AF, Vyakarnam A: Whey acidic proteins (WAPs): novel modulators of innate immunity to HIV infection. Curr Opin HIV AIDS 2012; 7:172-179.
13. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR: Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2010; 129:207-219.
14. Iqbal SM, Ball TB, Levinson P, Maranan L, Jaoko W, Wachihi C, Pak BJ, Podust VN, Broliden K, Hirbod T, Kaul R, Plummer FA: Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 2009; 23:1669-1677.
15. Fichorova RN, Anderson DJ: Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999; 60:508-514.
16. Cremel M, Berlier W, Hamzeh H, Cognasse F, Lawrence P, Genin C, Bernengo J-C, Lambert C, Dieu-Nosjean M-C, Delézay O: Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. J Leukoc Biol 2005; 78:158-166.
17. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR: CCL20/MIP3a is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 2009; 62:60-71.
18. Hickey DK, Patel MV, Fahey JV, Wira CR: Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 2011; 88:185-194.
19. Fahey JV, Wright JA, Shen L, Smith JM, Ghosh M, Rossoll RM, Wira CR: Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal Immunol 2008; 1:317-325.
20. Horne AW, Stock SJ, King AE: Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135:739-749.
21. Moriyama A, Shimoya K, Ogata I, Kimura T, Nakamura T, Wada H, Ohashi K, Azuma C, Saji F, Murata Y: Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod 1999; 5:656-661.
22. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC: Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002; 46:1896-1905.
23. Koks CAM, Dunselman GAJ, de Goeij AFPM, Arends JW, Evers JLH: Evaluation of a menstrual cup to collect shed endometrium for in vitro studies. Fertil Steril 1997; 68:560-564.
24. Crane-Godreau MA, Wira CR: Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture. Infect Immun 2005; 73:4231-4237.
25. Fahey JV, Bodwell JE, Hickey DK, Ghosh M, Muia MN, Wira CR: New approaches to making the microenvironment of the female reproductive tract hostile to HIV. Am J Reprod Immunol 2011; 65:334-343.
26. Barousse MM, Steele C, Dunlap K, Espinosa T, Boikov D, Sobel JD, Fidel PL: Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis 2001; 184:1489-1493.
27. Steele C, Fidel PL: Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002; 70:577-583.
28. Alderete JF, Demeś P, Gombosova A, Valent M, Fabusová M, Jánoska A, Stefanovic J, Arroyo R: Specific parasitism of purified vaginal epithelial cells by Trichomonas vaginalis. Infect Immun 1988; 56:2558-2562.
29. Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PE, Schalkwijk J: Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest 1996; 98:1389-1399.
30. Erhart W, Alkasi Ö, Brunke G, Wegener F, Maass N, Arnold N, Arlt A, Meinhold-Heerlein I: Induction of human β-defensins and psoriasin in vulvovaginal human papillomavirus-associated lesions. J Infect Dis 2011; 204:391-399.
31. Han JH, Kim MS, Lee MY, Kim TH, Lee M-K, Kim HR, Myung SC: Modulation of human β-defensin-2 expression by 17β-estradiol and progesterone in vaginal epithelial cells. Cytokine 2010; 49:209-214.
32. Coleman KD, Ghosh M, Crist SG, Wright JA, Rossoll RM, Wira CR, Fahey JV: Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol. Am J Reprod Immunol 2012; 67:44-53.
33. Benali R, Dupuit F, Chevillard M, Jacquot J, Haye B, Puchelle E: Modulations of the epithelial phenotype and functional activity of cultured bovine tracheal gland cells: dependence on the culture medium and passage number. Biol Cell 1991; 73:49-56.
34. Miessen K, Einspanier R, Schoen J: Establishment and characterization of a differentiated epithelial cell culture model derived from the porcine cervix uteri. BMC Vet Res 2012; 8:31.
35. Kato S, Espinoza N, Lange S, Villalon M, Cuello M, Owen GI: Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells. Tissue Cell 2008; 40:95-102.
36. Kumar R, Vicari M, Gori I, Achtari C, Fiche M, Surbeck I, Damnon F, Canny GO: Compartmentalized secretory leukocyte protease inhibitor expression and hormone responses along the reproductive tract of postmenopausal women. J Reprod Immunol 2011; 92:88-96.
37. Wagner RD, Johnson SJ: Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 2012; 19:58.
38. Farage MA, Maibach HI: Morphology and physiological changes of genital skin and mucosa. Curr Probl Dermatol 2011; 40:9-19.
39. Cunha GR, Cooke PS, Kurita T: Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 2004; 67:417-434.
40. Grant-Tschudy KS, Wira CR: Hepatocyte growth factor regulation of uterine epithelial cell transepithelial resistance and tumor necrosis factor alpha release in culture. Biol Reprod 2005; 72:814-821.
41. Kurita T, Lee KJ, Cooke PS, Taylor JA, Lubahn DB, Cunha GR: Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract. Biol Reprod 2000; 62:821-830.
42. Dutertre M, Smith CL: Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 2000; 295:431-437.
43. Hickey DK, Fahey JV, Wira CR: Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, α-/β-defensins and TLRs. Innate Immun 2012. doi: 10.1177/1753425912454026. [Epub ahead of print].
44. Hickey DK, Fahey JV, Wira CR: Estrogen receptor α antagonists mediate changes in CCL20 and CXCL1 secretions in the murine female reproductive tract. Am J Reprod Immunol 2012; 69:159-167.
45. Hickey DK, Wira CR: Beta-defensin 1-4 mRNA expression in the murine female reproductive tract is regulated by estrogen receptor ligand interactions. 2012.
46. Ochiel DO, Ghosh M, Fahey JV, Guyre PM, Wira CR: Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands. J Leukoc Biol 2010; 88:435-444.
47. Ochiel DO, Ochsenbauer C, Kappes JC, Ghosh M, Fahey JV, Wira CR: Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. PLoS ONE 2010; 5:e14306.
48. Berlier W, Cremel M, Hamzeh H, Levy R, Lucht F, Bourlet T, Pozzetto B, Delezay O: Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. Hum Reprod 2006; 21:1135-1142.
49. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-1917.